Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data

Fig. 2

Visual prediction check (VPC) of the final model of OS (a) and ALSFRS-R (b). Note: Points represent the observed OS and ALSFRS-R data, with point size proportional to the number of patients in each arm; The solid line is the model-predicted median of the disease course, and the dotted lines are the model-predicted 2.5th and 97.5th percentiles of the disease course, respectively

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172